This was the stock's second consecutive day of gains.

Quest Diagnostics DGX is set to release its fourth-quarter 2024 results on Jan. 30 before the market opens. Find the latest ...

Crossmark Global Holdings Inc. trimmed its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Quest Diagnostics Inc. succeeded in convincing a court to dismiss a lawsuit alleging it improperly shared patients’ data with ...

Quest Diagnostics Inc. closed $12.34 short of its 52-week high ($165.32), which the company reached on November 25th.

StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report ...

Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal ...

The "Cholesterol Testing Products and Services Market by Product, by Test Cholesterol Tests, by Application, by End-User, and ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.